Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.

Autor: Webb, M J, Neth, Bryan J, Webb, Lauren M, Gompel, Jamie J Van, Link, Michael J, Neff, Brian A, Carlson, Matthew L, Driscoll, Colin L, Dornhoffer, Jim, Ruff, Michael W, Anderson, Kelsey A, Kizilbash, Sani H, Campian, Jian L, Uhm, Joon H, Lane, Jack I, Benson, John C, Blezek, Daniel J, Mehta, Parv M, Bathla, Girish, Sener, Ugur T
Zdroj: Neuro-Oncology Advances; 2023, Vol. 5 Issue 1, p1-12, 12p
Databáze: Complementary Index